Abstract 5238: uPAR as a novel immunotherapeutic target in recurrent glioblastoma

作者
William Thomas Maich,Muhammad Vaseem Shaikh,Anish Puri,Alisha Anand,Chirayu Chokshi,Sabra Khalid Salim,Neil J. Savage,Chitra Venugopal,Martín A. Rossotti,Thomas Kislinger,Kevin A. Henry,Sheila Kumari Singh
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 5238-5238
标识
DOI:10.1158/1538-7445.am2024-5238
摘要

Abstract Glioblastoma (GBM) is the common malignant brain tumor in adults, accounting for approximately 15% of all CNS tumors, and 48.6% of malignant brain tumors, with a median survival of approximately 15 months, and minimal clinical progress having been made in the past two decades. GBM is characterized by extensive inter- and intra-tumoral heterogeneity as well as an extremely immunosuppressive tumor microenvironment. Following Standard-of-Care (SoC) surgical resection and chemoradiotherapy at primary diagnosis, few therapeutic avenues exist at recurrence, owing in part due to a lack of clinically relevant targets. Data from our multi-institutional target pipeline shows that the extracellular urokinase plasminogen activator receptor (uPAR) is significantly upregulated at recurrence on putative GBM brain tumor initiating cells (BTICs), which are believed to drive de novo tumor formation, tumor recurrence, and therapeutic resistance. uPAR plays an important role in the plasminogen activation system, and in the context of cancer, has been implicated in numerous pro-tumorigenic processes such as invasion, proliferation, epithelial-to-mesenchymal transition, and therapy resistance. We used CRISPR-Cas9 to genetically delete uPAR from our in-house patient-derived GBM cell lines, and found that in vitro, knockout of uPAR expression in recurrent GBM cells significantly reduces proliferation and sphere formation capacity, two stem-like traits associated with BTICs. Additionally, we found that uPAR knockout significantly reduced the frequency of BTICs in a given population. Additionally, uPAR knockout cells display increased sensitivity to standard-of-care chemoradiotherapy, implicating uPAR expression in therapy resistance, as seen in recurrent disease. We orthotopically injected immunocompromised mice to generate patient-derived xenograft models of GBM, and found that knockout of uPAR significantly increases survival, and decreases tumor burden. Further, we generated novel anti-uPAR single domain antibodies (sdAbs) and found that they specifically bind uPAR at low nanomolar concentrations in vitro. Using these sdAbs, we created an anti-uPAR CAR T which showed potent cytotoxicity in vitro, and drastically reduced tumor burden and extended survival in vivo. From this work we believe uPAR to be a clinically relevant target in recurrent GBM, and further investigation into therapeutic strategies to target uPAR-positive GBMs should be investigated further. Citation Format: William T. Maich, Muhammad Vaseem Shaikh, Anish Puri, Alisha Anand, Chirayu Chokshi, Sabra Salim, Neil Savage, Chitra Venugopal, Martin Rossotti, Thomas Kislinger, Kevin Henry, Sheila Singh. uPAR as a novel immunotherapeutic target in recurrent glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 5238.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
木染发布了新的文献求助10
1秒前
1秒前
bean发布了新的文献求助10
1秒前
1秒前
弄香完成签到,获得积分10
2秒前
2秒前
脑洞疼的应助被郑润意采纳,获得10
2秒前
3秒前
露露娜娜完成签到 ,获得积分10
3秒前
江就完成签到,获得积分10
3秒前
拓跋平萱发布了新的文献求助10
3秒前
LT发布了新的文献求助20
3秒前
杨沈芳辉发布了新的文献求助10
3秒前
积极衫发布了新的文献求助10
4秒前
wiken发布了新的文献求助10
4秒前
xy关闭了xy的文献求助
4秒前
在水一方的应助被GSR采纳,获得10
4秒前
传奇3的应助被瘦瘦的乌冬面采纳,获得10
4秒前
大模型的应助被舒适的秋尽采纳,获得10
4秒前
LFQlfc发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
上官若男的应助被零露采纳,获得20
6秒前
Yanzhang0000发布了新的文献求助10
6秒前
HermanCheney完成签到,获得积分10
6秒前
南有乔木发布了新的文献求助10
7秒前
7秒前
黎咩e茹发布了新的文献求助10
7秒前
slowww发布了新的文献求助10
8秒前
icNEo发布了新的文献求助200
8秒前
9秒前
adshie完成签到,获得积分20
9秒前
Orange的应助被威武渊思采纳,获得10
10秒前
10秒前
xtl发布了新的文献求助10
10秒前
万能图书馆的应助被yjw0526采纳,获得10
10秒前
10秒前
11秒前
zhu完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178449
求助须知:如何正确求助?哪些是违规求助? 9569267
关于积分的说明 21803160
捐赠科研通 7773332
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556833
邀请新用户注册赠送积分活动 2478436